Insmed Inc (MIL:1INSM)
€ 86.1 (0%) Market Cap: 18.61 Bil Enterprise Value: 18.05 Bil PE Ratio: 0 PB Ratio: 30.42 GF Score: 45/100

Insmed Inc at TD Cowen Healthcare Conference Transcript

Mar 02, 2026 / 02:50PM GMT
Release Date Price: €125 (-11.35%)
Ritu Baral
Cowen and Company LLC - Analyst

Here we go. All right. Welcome, everyone, to the Insmed fireside chat at the TD Cowen Healthcare Conference. I am covering analyst Ritu Baral. And with me from Insmed is CEO, Will Lewis. Thank you, Will, for being here.

Questions & Answers

Ritu Baral;William Lewis
Cowen and Company LLC - Analyst;Insmed Inc - Chairman of the Board

A big couple of years for you guys ever since the BRINSUPRI Phase 3 data 18 months ago, two years ago. We'll start there. That is the major topic of conversation. It was the major topic conversation yesterday when I hosted you guys for dinner and a number of you guys.

You posted very impressive Q4 numbers of 144. I think even buy-side consensus was less than half that. Sell-side consensus was much lower than that even. What are -- right now, the key drivers behind -- well, what were the key drivers in Q4 and how is that evolving into Q1? Given the caution that you communicated in January at another investor conference, how is that evolving?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot